Table 5

Mortality among patients with hip fractures in the non-DM, OAD, and insulin cohorts

MortalityModel IModel II
n(%)n(%)Adjusted HR (95% CI)P valueAdjusted HR (95% CI)P value
Non-DM cohort2263−82.4482−17.6Ref
OAD cohort2020(85.1)353(14.9)0.86 (0.75 to 0.98)0·026Ref
Insulin cohort276(74.2)96(25.8)1.48 (1.19 to 1.85)<0·0011.69 (1.35 to 2.13)<0.001
  • Adjusted for age, sex, payroll bracket table, anesthesia type, and Charlson Comorbidity Index score.

  • Model I: comparison among the non-DM (ref), OAD, and insulin cohorts.

  • Model II: comparison between the OAD (ref) and insulin cohorts.

  • DM, diabetes mellitus; OAD, oral antidiabetic drug; ref, reference.